The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Enrolling underrepresented patients in thoracic cancer clinical trials
Frank Weinberg, MD, PhD, University of Illinois Chicago, Chicago, IL, discusses an analysis of clinical trial enrollment at a center serving underrepresented communities in Chicago. The study found that whilst patient enrollment in trials was above the national average, significant racial disparities were identified. Trust in institutions and understanding of the clinical trials themselves were factors behind these disparities in underrepresented communities. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
